Inhaled Antibiotics Market Poised for Rapid Growth with Rising Respiratory Infections
The global Inhaled Antibiotics market is witnessing significant growth due to the increasing prevalence of respiratory infections and the need for targeted drug delivery solutions. Inhaled antibiotics are critical in managing lung infections, particularly in patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), and hospital-acquired infections. With advances in aerosolized drug formulations and nebulizer technologies, the adoption of inhaled antibiotics is set to expand across hospitals, clinics, and homecare settings.
Read Full Research Study: https://marketintelo.com/repor....t/inhaled-antibiotic
